• Careers
  • Apply
  • Events
    • Global
    • Local
  • News
  • Contact
  • Careers
  • Apply
  • Events
    • Global
    • Local
  • News
  • Contact
23
Feb

Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck Cancer

Cancer management, Cancer treatment
Adding docetaxel to radiation therapy improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomised trial showed.
PrevNext

Related Posts

May 9, 2022

RANZCR Submission to the Australian Cancer Plan 2023 – 2033

increaseoNews0
April 30, 2018

Research to help diagnose and treat cancer faster

GCG Global HealthcareNews0
April 9, 2018

DBT improves breast cancer screening in young women

GCG Global HealthcareNews0

Latest News

  • 5 key trends in PACS and enterprise imaging from Signify Research
  • Advanced PET/MRI protocols boost lung cancer detection
  • FDA clears new AI-powered cardiac imaging solution

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.

RSS Health Pulse

  • Is 'climate anxiety' a clinical diagnosis? Should it be?
  • What causes hiccups and how can you get rid of them?
  • TGA review strengthens case for much tighter vape restrictions at the border

Twitter

  • Amy Thompson, a senior analyst at Signify Research, explains what she is seeing in the market for radiology PACS an… https://t.co/rPyNpufEmG 12 hours ago
  • PET/MRI achieves similar or superior results to PET/CT for the detection of pulmonary malignancies, according to ne… https://t.co/xreCTlkiok 3 days ago
  • DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. FDA clearance for LVivo IQS, a… https://t.co/14Y4F4TGMP 5 days ago
© GCG Global Healthcare Pty Ltd, All rights reserved. ABN 25 136 716 991

Find your next opportunity with
GCG Global Healthcare TODAY!

DISCOVER OUR OPEN POSITIONS NOW!